Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$12.3M Buy
103,897
+25,260
+32% +$2.92M 0.2% 90
2014
Q1
$9.7M Buy
78,637
+1,357
+2% +$165K 0.17% 100
2013
Q4
$8.81M Buy
77,280
+1,061
+1% +$121K 0.15% 109
2013
Q3
$8.53M Buy
76,219
+847
+1% +$91.8K 0.15% 105
2013
Q2
$7.43M Buy
+75,372
New +$7.82M 0.15% 115

Other funds holding AMGN

Wilmington Trust's AMGN Position: Q2 2014 in Review

Wilmington Trust increased its Amgen (AMGN) stake by 32% in Q2 2014, buying an estimated $2.92M and bringing the position to 103,897 shares worth $12.3M. The position accounts for 0.2% of the portfolio, ranked #90.

Wilmington Trust first reported a position in AMGN in Q2 2013 and has held it in 5 quarters since. 1,186 funds tracked by Wall St. Rank hold AMGN as of Q2 2014.

  • Wilmington Trust held 103,897 shares of Amgen worth $12.3M as of Q2 2014.
  • Wilmington Trust bought 25,260 Amgen shares in Q2 2014, an estimated $2.92M.
  • Amgen made up 0.2% of Wilmington Trust's portfolio in Q2 2014, its #90 holding.
  • Wilmington Trust first reported a position in Amgen in Q2 2013 and has held it in 5 quarters since.
  • 1,186 funds tracked by Wall St. Rank held Amgen as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.